Streptococcus pneumoniae serotype 4 capsular polysaccharide

The **Streptococcus pneumoniae serotype 4 capsular polysaccharide** is a high-molecular-weight carbohydrate polymer that forms the outer capsule of *S. pneumoniae* bacteria belonging to serotype 4. This capsule is composed of tetrasaccharide repeating units with unique structural features, notably a rare cyclic trans-(2,3) pyruvate ketal modification on one sugar residue[2][3]. The capsule serves as the primary virulence factor for *S. pneumoniae*, enabling it to evade phagocytosis by neutrophils and other components of the innate immune system, thereby facilitating colonization and infection in humans[7][8]. The structure of this specific capsular polysaccharide determines its immunogenic properties—antibodies targeting these structures can mediate protective immunity against invasive pneumococcal disease caused by serotype 4 strains. As such, purified or synthetic versions are included as antigens in licensed pneumococcal vaccines for active immunization against diseases like pneumococcal pneumonia and bacteremia[2][3][5]. The presence or absence of certain modifications—such as pyruvylation—can significantly affect antibody recognition; thus, these structural motifs are critical for effective vaccine design. In summary, this molecule is not a receptor or enzyme but rather an essential bacterial surface glycan targeted by current vaccines due to its central role in pathogenesis and immune recognition.

Other names

Streptococcus pneumoniae type 4 capsular polysaccharide antigenPneumococcal polysaccharide serotype 4Streptococcus pneumoniae type 4 polysaccharide antigenPneumococcal capsular polysaccharide type 4 vaccine

Induces active acquired immunity by stimulating the production of anti-capsular antibodies that promote opsonophagocytosis and clearance of S. pneumoniae from the host